Co-occurring genomic alterations and immunotherapy efficacy in NSCLC

An oncogene-centric molecular classification paradigm in non-small cell lung cancer (NSCLC) has been established. Of note, the heterogeneity within each oncogenic driver-defined subgroup may be captured by co-occurring mutations, which potentially impact response/resistance to immune checkpoint inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fan, Wang, Jinliang, Xu, Yu, Cai, Shangli, Li, Tao, Wang, Guoqiang, Li, Chengcheng, Zhao, Lei, Hu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766442/
https://www.ncbi.nlm.nih.gov/pubmed/35042953
http://dx.doi.org/10.1038/s41698-021-00243-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766442/
https://www.ncbi.nlm.nih.gov/pubmed/35042953
http://dx.doi.org/10.1038/s41698-021-00243-7

Ejemplares similares